These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 11068635

  • 1. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
    Furlan M.
    Adv Nephrol Necker Hosp; 2000; 30():71-81. PubMed ID: 11068635
    [No Abstract] [Full Text] [Related]

  • 2. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B.
    N Engl J Med; 1998 Nov 26; 339(22):1578-84. PubMed ID: 9828245
    [Abstract] [Full Text] [Related]

  • 3. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura--new insights into underlying biochemical mechanisms.
    Furlan M, Lämmle B.
    Nephrol Dial Transplant; 2000 Aug 26; 15(8):1112-4. PubMed ID: 10910429
    [No Abstract] [Full Text] [Related]

  • 4. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Sarkodee-Adoo C, Gojo I, Heyman MR.
    N Engl J Med; 1999 Apr 29; 340(17):1368; author reply 1369. PubMed ID: 10223876
    [No Abstract] [Full Text] [Related]

  • 5. Recent observations on the pathophysiology of thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL.
    Hematol Pathol; 1990 Apr 29; 4(4):197-201. PubMed ID: 2074261
    [No Abstract] [Full Text] [Related]

  • 6. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
    Moake JL.
    Prog Clin Biol Res; 1990 Apr 29; 337():135-40. PubMed ID: 2191307
    [No Abstract] [Full Text] [Related]

  • 7. Controversies in differentiating thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Shah NT, Rand JH.
    Mt Sinai J Med; 2003 Oct 29; 70(5):344-51. PubMed ID: 14631521
    [Abstract] [Full Text] [Related]

  • 8. [Plasma exchange therapy in patients with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome].
    Ikeda Y, Kikuchi M.
    Nihon Rinsho; 1992 Jan 29; 50 Suppl():293-7. PubMed ID: 1578694
    [No Abstract] [Full Text] [Related]

  • 9. Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families. The Italian Registry of Familial and Recurrent HUS/TTP.
    Galbusera M, Noris M, Rossi C, Orisio S, Caprioli J, Ruggeri ZM, Amadei B, Ruggenenti P, Vasile B, Casari G, Remuzzi G.
    Blood; 1999 Jul 15; 94(2):610-20. PubMed ID: 10397728
    [Abstract] [Full Text] [Related]

  • 10. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Warwicker P, Goodship JA, Goodship TH.
    N Engl J Med; 1999 Apr 29; 340(17):1368-9. PubMed ID: 10223877
    [No Abstract] [Full Text] [Related]

  • 11. Ultralarge von Willebrand factor-induced platelet clumping and activation of the alternative complement pathway in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromes.
    Turner N, Sartain S, Moake J.
    Hematol Oncol Clin North Am; 2015 Jun 29; 29(3):509-24. PubMed ID: 26043389
    [Abstract] [Full Text] [Related]

  • 12. Thrombotic microangiopathies.
    Moake JL.
    N Engl J Med; 2002 Aug 22; 347(8):589-600. PubMed ID: 12192020
    [No Abstract] [Full Text] [Related]

  • 13. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L.
    Nephrol Nurs J; 2002 Apr 22; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [Abstract] [Full Text] [Related]

  • 14. Significance of endothelial deposition of von Willebrand factor in thrombotic thrombocytopenic purpura: autopsy findings of a case complicated with systemic lupus erythematosus.
    Ono T, Kawaguchi K, Onaka H, Ueda S, Inui T, Nagai H, Matsuo T, Kuwahara T.
    Nihon Jinzo Gakkai Shi; 1993 Jan 22; 35(1):79-82. PubMed ID: 8336404
    [Abstract] [Full Text] [Related]

  • 15. Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies.
    Mayer SA, Aledort LM.
    Mt Sinai J Med; 2005 May 22; 72(3):166-75. PubMed ID: 15915311
    [Abstract] [Full Text] [Related]

  • 16. Report on the workshop: Von Willebrand factor and Thrombotic Thrombocytopenic Purpura.
    Moake JL, Sadler JE, Mannucci P, Ganguly P.
    Am J Hematol; 2001 Oct 22; 68(2):122-6. PubMed ID: 11559952
    [No Abstract] [Full Text] [Related]

  • 17. Familial and recurrent forms of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura.
    Noris M, Remuzzi G.
    Contrib Nephrol; 2001 Oct 22; (136):125-39. PubMed ID: 11688376
    [No Abstract] [Full Text] [Related]

  • 18. [Diagnostic criteria and differential diagnosis of thrombotic thrombocytopenic purpura].
    Pardo Vigo A, Zamora de Pedro C, Hernández Jodra M.
    Rev Clin Esp; 2000 Dec 22; 200(12):685-7. PubMed ID: 11234475
    [No Abstract] [Full Text] [Related]

  • 19. von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL, McPherson PD.
    Transfus Med Rev; 1990 Apr 22; 4(2):163-8. PubMed ID: 2134624
    [No Abstract] [Full Text] [Related]

  • 20. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.
    Mol Immunol; 2009 Sep 22; 46(14):2801-7. PubMed ID: 19640589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.